Read + Share
Busnadiego I, Abela IA, Frey PM, Hofmaenner DA, et al. Critically ill COVID-19 patients with neutralizing autoantibodies against type I
interferons have increased risk of herpesvirus disease. PLoS Biol 2022;20:e3001709.
PMID: 35788562
|
 |
|
Busnadiego I, Abela IA, Frey PM, Hofmaenner DA, et al. Critically ill COVID-19 patients with neutralizing autoantibodies against type I
interferons have increased risk of herpesvirus disease. PLoS Biol 2022;20:e3001709.
PMID: 35788562
|
|
|
|